Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neuro-immunology
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Related Questions
Is IVIG ever used to treat CNS neurosarcoidosis–related pain when the presentation is not consistent with peripheral neurosarcoid involvement?”
When, if ever, do you use therapeutic hypothermia (targeted temperature management) in a non-neotal pediatric cardiac arrest patient?
When do you switch to a different DMT in multiple sclerosis patients planning for pregnancy?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
What biomarkers best predict the response to B-cell depleting therapies in MS?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
